Research Topics
| Joel M GelfandSummaryAffiliation: University of Pennsylvania Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice settingJoel M Gelfand
Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
Arch Dermatol 148:487-94. 2012..To compare the effectiveness of biologic systemic therapy, nonbiologic systemic therapy, and phototherapy for treatment of psoriasis...
Risk of myocardial infarction in patients with psoriasisJoel M Gelfand
Department of Dermatology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA 19104, USA
JAMA 296:1735-41. 2006..Psoriasis has been associated with cardiovascular diseases, but has only been investigated in hospital-based studies that did not control for major cardiovascular risk factors...
The risk of lymphoma in patients with psoriasisJoel M Gelfand
Department of Dermatology and Center for Clinical Epidemiology and Biostatistics University of Pennsylvania, Philadelphia, 19104, USA
J Invest Dermatol 126:2194-201. 2006..Although patients with psoriasis have an increased relative risk of lymphoma, the absolute risk attributable to psoriasis is low given that lymphoma is a rare disease and the magnitude of association is modest...
Prevalence and treatment of psoriasis in the United Kingdom: a population-based studyJoel M Gelfand
Center for Clinical Epidemiology and Biostatistics, and Department of Dermatology, University of Pennsylvania, 3600 Spruce Street, 2 Maloney Building, Philadelphia, PA 19104, USA
Arch Dermatol 141:1537-41. 2005..To measure the prevalence and treatment of psoriasis in the United Kingdom...
Epidemiology of psoriatic arthritis in the population of the United StatesJoel M Gelfand
Department of Dermatology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA 19104, USA
J Am Acad Dermatol 53:573. 2005..Estimates of the prevalence of psoriatic arthritis vary widely and are usually not determined by population-based studies...
Psoriasis and cardiovascular risk: strength in numbers, part IIJoel M Gelfand
Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
J Invest Dermatol 131:1007-10. 2011....
The prevalence of psoriasis in African Americans: results from a population-based studyJoel M Gelfand
Department of Dermatology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, PA 19104, USA
J Am Acad Dermatol 52:23-6. 2005..The prevalence of psoriasis in African Americans has been previously reported as rare. However, there have been no population-based studies to assess the prevalence and burden of psoriasis in African Americans...
The risk of stroke in patients with psoriasisJoel M Gelfand
Department of Dermatology, University of Pennsylvania School of Medicine, Pennsylvania, PA 19104, USA
J Invest Dermatol 129:2411-8. 2009..Patients with psoriasis, particularly if severe, have an increased risk of stroke that is not explained by major stroke risk factors identified in routine medical care...
The risk of mortality in patients with psoriasis: results from a population-based studyJoel M Gelfand
MSCE, Department of Dermatology, University of Pennsylvania School of Medicine, 2 Maloney Bldg, 3600 Spruce St, Philadelphia, PA 19104, USA
Arch Dermatol 143:1493-9. 2007..To determine the risk of mortality in patients with psoriasis...
Psoriasis and cardiovascular risk: strength in numbersJoel M Gelfand
Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
J Invest Dermatol 130:919-22. 2010..This negative result should be interpreted in light of the study's limitations, the complex relationship among levels of psoriasis severity, patient age, and cardiovascular (CV) risk, and the context of the rapidly growing literature...
Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasisHowa Yeung
Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA
J Am Acad Dermatol 68:64-72. 2013..Despite widespread dissatisfaction and low treatment persistence in moderate to severe psoriasis, patients' reasons behind treatment discontinuation remain poorly understood...
Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patientsJoy Wan
Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA
J Am Acad Dermatol 66:376-86. 2012..Despite increasing therapies for moderate to severe psoriasis, dermatologists' treatment preferences are unknown...
Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United KingdomSinead M Langan
Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK
J Invest Dermatol 132:556-62. 2012..These findings suggest that screening for metabolic disease should be considered for psoriasis, especially when it is severe...
Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasisKatrina Abuabara
Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
J Am Acad Dermatol 68:262-9. 2013..Physician perceptions can influence prescribing patterns and patient outcomes, and may help to explain variations in clinical practice...
Prevalence of cardiovascular risk factors in patients with psoriasisAndrea L Neimann
Dermatology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
J Am Acad Dermatol 55:829-35. 2006..CONCLUSION: Multiple cardiovascular risk factors are associated with psoriasis. Cardiovascular risk factors that are key components of the metabolic syndrome are more strongly associated with severe psoriasis than with mild psoriasis...
Immunosuppressant medications and mortality in inflammatory bowel diseaseJames D Lewis
Division of Gastroenterology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Am J Gastroenterol 103:1428-35; quiz 1436. 2008..This study examined whether treatment of Crohn's disease (CD) and ulcerative colitis (UC) with immunosuppressant medications was associated with an increased risk of death in the era prior to antitumor necrosis factor (TNF) therapies...
Attributable risk estimate of severe psoriasis on major cardiovascular eventsNehal N Mehta
Preventive Cardiology, Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, USA
Am J Med 124:775.e1-6. 2011..We compared the risk of major adverse cardiac events between patients with psoriasis and the general population and estimated the attributable risk of severe psoriasis...
Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research DatabaseNehal N Mehta
Cardiovascular Institute, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Eur Heart J 31:1000-6. 2010..We conducted a cohort study using the General Practice Research Database to determine if severe psoriasis patients have an increased risk of cardiovascular (CV) mortality...
Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasisRahat S Azfar
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA 16104, USA
Arch Dermatol 148:995-1000. 2012..To assess the risk of incident diabetes mellitus (DM) in patients with psoriasis and to evaluate DM treatment patterns among patients with psoriasis and incident DM...
Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United KingdomJoel M Gelfand
Department of Dermatology and the Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadephia 19104, USA
Arch Dermatol 139:1425-9. 2003..Additional studies are necessary to determine if the increased rate of lymphoma is related to psoriasis severity, psoriasis treatment, or an interaction between these risk factors...
Determinants of quality of life in patients with psoriasis: a study from the US populationJoel M Gelfand
Department of Dermatology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, USA
J Am Acad Dermatol 51:704-8. 2004..CONCLUSION: Patients with more extensive skin involvement have greater reductions in quality of life. Female patients and young patients are affected to a greater extent...
The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort studyShanu Kohli Kurd
Department of Medicine, University of Pennsylvania, 3600 Spruce Street, Philadelphia, PA 19104, USA
Arch Dermatol 146:891-5. 2010..To determine the incidence of depression, anxiety, and suicidality in patients with psoriasis compared with the general population...
Is there truly a risk of lymphoma from biologic therapies?Erica Dommasch
Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
Dermatol Ther 22:418-30. 2009..Continued vigilance is warranted; however, in the appropriate patient, the risk-to-benefit profile of psoriasis treatment with respect to lymphoma risk appears highly favorable...
National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screeningAlexa B Kimball
Department of Dermatology, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts 02114, USA
J Am Acad Dermatol 58:1031-42. 2008....
Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasisNehal N Mehta
Cardiovascular Institute, University of Pennsylvania School of Medicine, USA
Atherosclerosis 224:218-21. 2012..We sought to study how chronic in vivo inflammation modulates lipoprotein particle composition using nuclear magnetic resonance spectroscopy (NMR) and HDL efflux in psoriasis...
Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trialShanu Kohli Kurd
Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
J Am Acad Dermatol 58:625-31. 2008..There is a need for safe, inexpensive, and effective psoriasis therapies. Many anecdotal accounts of patients' successful treatment with the alternative medicine curcumin exist...
The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trialsErica D Dommasch
Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
J Am Acad Dermatol 64:1035-50. 2011..There is a need to better understand the safety of tumor necrosis factor (TNF) inhibitors in patients with psoriatic disease in whom TNF inhibitors are frequently used as monotherapy...
Metabolic syndrome in patients with psoriatic diseaseJoel M Gelfand
Department of Dermatology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
J Rheumatol Suppl 89:24-8. 2012..Further research will be necessary to establish the directionality of this association and to explore the effect of treatment on these comorbid diseases...
Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: continuous versus interrupted treatmentJoel M Gelfand
Department of Dermatology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA
Value Health 11:400-7. 2008..The objective of this analysis was to assess patient-reported outcomes (PROs) and health-care resource utilization (HRU) data from the EASE study...
From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasisMark Lebwohl
Department of Dermatology, Mount Sinai School of Medicine, New York, New York, USA
J Am Acad Dermatol 58:94-105. 2008..Biologics are widely used in the treatment of psoriasis and psoriatic arthritis...
Consensus guidelines for the management of plaque psoriasisSylvia Hsu
Department of Dermatology, Baylor College of Medicine, Houston, TX 77030, USA
Arch Dermatol 148:95-102. 2012....
Test characteristics of high-resolution ultrasound in the preoperative assessment of margins of basal cell and squamous cell carcinoma in patients undergoing Mohs micrographic surgeryAnokhi Jambusaria-Pahlajani
Department of Dermatology, University of Pennsylvannia, Philadelphia, Pennsylvania, USA
Dermatol Surg 35:9-15; discussion 15-6. 2009..Noninvasive techniques to assess subclinical spread of nonmelanoma skin cancer (NMSC) may improve surgical precision. High-resolution ultrasound has shown promise in evaluating the extent of NMSC...
The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004Shanu Kohli Kurd
Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
J Am Acad Dermatol 60:218-24. 2009..Psoriasis is a predictor of morbidity. It is important to determine the extent to which psoriasis remains undiagnosed...
Surrogate end points for the treatment of diabetic neuropathic foot ulcersDavid J Margolis
Department of Dermatology and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
Diabetes Care 26:1696-700. 2003....
Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot studyNehal N Mehta
Cardiovascular Institute, University of Pennsylvania School of Medicine, 6 Penn Tower, Philadelphia, PA 19104, USA
Arch Dermatol 147:1031-9. 2011..To evaluate the feasibility of using [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT) to detect and quantify systemic inflammation in patients with psoriasis...
Aortic vascular inflammation in psoriasis is associated with HDL particle size and concentration: a pilot studyYiding Yu
Cardiovascular Institute, University of Pennsylvania 6 Penn Tower, Philadelphia, Pennsylvania, USA
Am J Cardiovasc Dis 2:285-92. 2012..These findings suggest that HDL particle characteristics may play an important role in psoriatic vascular inflammation and CVD...
High clinical response rate of Sezary syndrome to immunomodulatory therapies: prognostic markers of responseBrian A Raphael
Department of Dermatology, The Hospital at the University of Pennsylvania, Philadelphia, USA
Arch Dermatol 147:1410-5. 2011..To quantify response rates of Sézary syndrome (SS) to multimodality immunomodulatory therapy and to identify the important prognostic parameters that affect overall response to treatment...
National Psoriasis Foundation clinical consensus on disease severityDavid M Pariser
Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA
Arch Dermatol 143:239-42. 2007....
Increased risk for demyelinating diseases in patients with inflammatory bowel diseaseGauree Gupta
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6021, USA
Gastroenterology 129:819-26. 2005..Future studies should clarify whether treatment with tumor necrosis factor alpha blockers results in further increased incidence of MS/D/ON among IBD patients...
Curcuminoids activate p38 MAP kinases and promote UVB-dependent signalling in keratinocytesElias E Ayli
Department of Dermatology, University of Pennsylvania Medical School, Philadelphia, PA, USA
Exp Dermatol 19:493-500. 2010..Curcuminoids also synergize with UVB to enhance p53 phosphorylation. The findings provide a rationale for testing curcuminoids in disorders associated with impaired p53 function or in which UVB-treatment is efficacious...
Psoriasis and metabolic disease: epidemiology and pathophysiologyRahat S Azfar
Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Curr Opin Rheumatol 20:416-22. 2008..Increasingly, epidemiological studies are establishing the directionality of these associations and psoriasis' role as an independent risk factor in developing these outcomes...
Seeing red: flushing out instigators of niacin-associated skin toxicityRichard L Dunbar
Department of Medicine, Division of Experimental Therapeutics, Institute for Translational Medicine and Therapeutics, Pennsylvania 19104, USA
J Clin Invest 120:2651-5. 2010..These efforts bring us one step closer to solving a key limitation of an important cardioprotective drug and reveal that the skin response to niacin is much more complicated than previously thought...
High prevalence of aquagenic wrinkling of the palms in patients with cystic fibrosis and association with measurable increases in transepidermal water lossLisa M Arkin
Department of Pediatrics, Children s Hospital of Philadelphia, Philadelphia, PA 19104, USA
Pediatr Dermatol 29:560-6. 2012..Aquagenic wrinkling of the palms is prevalent in children with CF and is associated with increased TEWL...
Epstein-Barr virus and human herpesvirus type 6 infection in patients with psoriasisAndrea L Neimann
Department of Dermatology, University of Pennsylvania, 3600 Spruce Street, 2 Maloney Building, Philadelphia, PA 19104, USA
Eur J Dermatol 16:548-52. 2006..11). The results of this study suggest that neither severe psoriasis alone, nor in combination with immunosuppressive therapy, is associated with an increase in Epstein-Barr virus or human herpesvirus 6 replication in white blood cells...
Complementary and alternative medicine for psoriasis: a qualitative review of the clinical trial literatureNana Smith
Department of Dermatology, University of Rochester, Rochester, New York, USA
J Am Acad Dermatol 61:841-56. 2009..Patients with psoriasis often inquire about complementary and alternative medicine in an effort to do everything possible to control the disease...
Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphomaMaria Wysocka
Department of Dermatology, University of Pennsylvania, Philadelphia, PA 19104, USA
Leuk Lymphoma 52:1970-9. 2011..These results further support our hypothesis that combinations of biological modifiers activating different arms of the immune system may provide significant therapeutic benefits for patients with advanced CTCL...
A randomized, double-blind comparison of the total dose of 1.0% lidocaine with 1:100,000 epinephrine versus 0.5% lidocaine with 1:200,000 epinephrine required for effective local anesthesia during Mohs micrographic surgery for skin cancersPamela A Morganroth
Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
J Am Acad Dermatol 60:444-52. 2009..We sought to compare total lidocaine dose and patient comfort when using 1.0% lidocaine with 1:100,000 epinephrine versus 0.5% lidocaine with 1:200,000 epinephrine during Mohs micrographic surgery...
A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativaRobert A Lee
Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
J Am Acad Dermatol 60:565-73. 2009..Medical therapies for hidradenitis suppurativa (HS) are often ineffective. Tumor necrosis factor-alpha inhibitors may be a potential treatment for patients with moderate to severe HS...
Synthetic imidazoquinolines potently and broadly activate the cellular immune response of patients with cutaneous T-cell lymphoma: synergy with interferon-gamma enhances production of interleukin-12Maria Wysocka
Department of Dermatology, University of Pennsylvania, PA 19104, USA
Clin Lymphoma Myeloma 7:524-34. 2007....
Use of complementary and alternative medicine among adults with skin disease: results from a national surveyNana Smith
Department of Dermatology, University of Rochester, Rochester, New York 14642, USA
J Am Acad Dermatol 60:419-25. 2009..Complementary and alternative medicine (CAM) is commonly used for a variety of diseases in the United States. Limited population-based data exist on CAM use among patients with dermatologic conditions..
The epidemiology of atopic dermatitisRoss M Levy
Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
Clin Dermatol 21:109-15. 2003
Prevalence and treatment patterns of psoriatic arthritis in the UKAlexis Ogdie
Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 8 Penn Tower, 1 Convention Ave, Philadelphia, PA 19104, USA
Rheumatology (Oxford) 52:568-75. 2013....
The epidemiology of sunburn in the US population in 2003Tamu T Brown
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
J Am Acad Dermatol 55:577-83. 2006..CONCLUSION: Sunburn occurs at a very high rate in the United States...
Update on the epidemiology and systemic treatment of psoriasisShanu Kohli Kurd
Jefferson Medical College, Philadelphia, PA, USA
Expert Rev Clin Immunol 3:171-85. 2007..In this article, we focus on recent developments in the epidemiology and systemic treatment of psoriasis...
Assessing long-term drug safety: lessons (re) learned from raptivaNicole M Seminara
Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA
Semin Cutan Med Surg 29:16-9. 2010..Patients and clinicians need to be aware of the relative completeness and limitations of existing safety data of a drug when selecting a treatment...
Srcasm overexpression in psoriasis-insights into pathogenesisMelissa Pulitzer
Department of Dermatology, University of Pennsylvania Medical School, Philadelphia, PA, USA
J Cutan Pathol 34:160-5. 2007..In this study, the levels of Srcasm mRNA and protein are characterized, and the relationship of these experimental observations to the psoriasis pathogenesis is discussed...
Surrogate endpoints for the treatment of venous leg ulcersJoel M Gelfand
Department of Dermatology and the Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA 19104, USA
J Invest Dermatol 119:1420-5. 2002....
Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndromeCamille E Introcaso
Department of Dermatology, The University of Pennsylvania, Philadelphia, Pennsylvania, USA
J Am Acad Dermatol 53:428-34. 2005..Further prospective analysis involving larger groups of patients is recommended...
Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patientsTamar Nijsten
Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands
J Invest Dermatol 127:2315-22. 2007..Therefore, these instruments should not be used in their current form in international studies...
CD8+ lymphoma in a patient with human immunodeficiency virusChad M Hivnor
Arch Dermatol 141:1321-2. 2005
Long-term treatment for severe psoriasis: we're halfway there, with a long way to goJoel M Gelfand
Arch Dermatol 143:1191-3. 2007
The role of topical therapy for patients with extensive psoriasisSteven R Feldman
Center for Dermatology Research, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA
Cutis 79:18-31. 2007..Advantages of the 2-compound ointment include rapid onset of action and a relative lack of systemic toxicity. This effective topical agent may expand the psoriasis population that can be considered candidates for topical treatment...
Research Grants
- Surrogate markers of complete venous ulcer healingJoel Gelfand; Fiscal Year: 2002..Through conducting these studies and pursuing the MSCE, the investigator will develop a series of epidemiological tools for which to apply to future scientific investigations. ..
- Investigating the Risk of Lymphoma in Psoriasis PatientsJoel Gelfand; Fiscal Year: 2007....
- The Risk of Myocardial Infarction in Patients with PsoriasisJoel M Gelfand; Fiscal Year: 2010..Furthermore, to our knowledge, this will be the first analytic study of the risk of stroke in patients with psoriasis, and the first study to examine how psoriasis skin severity impacts the risk of MI. ..
- The Risk of Myocardial Infarction in Patients with PsoriasisJoel M Gelfand; Fiscal Year: 2010..Furthermore, to our knowledge, this will be the first analytic study of the risk of stroke in patients with psoriasis, and the first study to examine how psoriasis skin severity impacts the risk of MI. ..
